Publication | Closed Access
First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases
430
Citations
29
References
2005
Year
223Ra was well tolerated at therapeutically relevant dosages. Phase II studies have therefore been initiated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1